Charles R. Salmen
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles R. Salmen.
Journal of Ethnopharmacology | 2011
Jason M. Nagata; Alan R. Jew; John M. Kimeu; Charles R. Salmen; Elizabeth A. Bukusi; Craig R. Cohen
ETHNOPHARMACOLOGICAL RELEVANCE Given the increasing coverage of antiretroviral therapy (ART) for HIV/AIDS treatment as well as the high utilization of herbal medicine, many persons living with HIV/AIDS in sub-Saharan Africa are thought to practice medical pluralism, or the adoption of more than one medical system for their care and treatment. Using a cross-sectional study we sought to document and identify the herbal medicines used by persons living with HIV/AIDS on Mfangano Island, Suba District, Nyanza Province, Kenya. MATERIALS AND METHODS We interviewed herbalists and knowledgeable mothers to obtain information regarding medicinal plants, particularly for HIV/AIDS-related symptoms, HIV/AIDS, and chira (an illness concept with similarities to HIV/AIDS regarding sexual transmission and wasting symptoms). Using systematic sampling, 67 persons living with HIV/AIDS (49 of whom were receiving ART) were selected from an Mfangano Island health clinic and participated in semi-structured interviews. RESULTS Interviews with herbalists and mothers identified 40 plant species in 37 genera and 29 families that a person with HIV/AIDS or chira could use for herbal remedies. Overall, 70.1% of persons living with HIV/AIDS had used medicinal plants after HIV diagnosis, most commonly to treat symptoms related to HIV/AIDS. In addition to common vegetables and fruits that can serve medicinal purposes, Azadirachta indica A. Juss. (Meliaceae), Carissa edulis (Forssk.) Vahl (Apocynaceae), and Ximenia americana L. (Olacaceae) were the most frequently cited medicinal plants used by persons living with HIV/AIDS. CONCLUSIONS Collaboration and communication between biomedical clinicians and herbalists should be encouraged given high rates of concomitant ART-herb usage. Pharmacological, toxicological, and ART-herb interaction studies based on the plants identified in this study and their constituent ingredients should be considered.
Journal of Acquired Immune Deficiency Syndromes | 2014
Matthew D. Hickey; Charles R. Salmen; Robert Tessler; Dan Omollo; Peter Bacchetti; Richard Magerenge; Brian Mattah; Marcus R. Salmen; Daniel Zoughbie; Kathryn J. Fiorella; Elvin Geng; Betty Njoroge; Chengshi Jin; Yong Huang; Elizabeth A. Bukusi; Craig R. Cohen; Monica Gandhi
Abstract:Antiretroviral hair levels objectively quantify drug exposure over time and predict virologic responses. We assessed the acceptability and feasibility of collecting small hair samples in a rural Kenyan cohort. Ninety-five percentage of participants (354/373) donated hair. Although median self-reported adherence was 100% (interquartile range, 96%–100%), a wide range of hair concentrations likely indicates overestimation of self-reported adherence and the advantages of a pharmacologic adherence measure. Higher nevirapine hair concentrations observed in women and older adults require further study to unravel behavioral versus pharmacokinetic contributors. In resource-limited settings, hair antiretroviral levels may serve as a low-cost quantitative biomarker of adherence.
Ecology of Food and Nutrition | 2015
Jason M. Nagata; Kathryn J. Fiorella; Charles R. Salmen; Matthew D. Hickey; Brian Mattah; Richard Magerenge; Erin M. Milner; Sheri D. Weiser; Elizabeth A. Bukusi; Craig R. Cohen
The objective of this study was to investigate the relationship among socioeconomic status, social support, and food insecurity in a rural Kenyan island community. A cross-sectional random sample of 111 female heads of households representing 583 household members were surveyed in Mfangano Island, Kenya from August to October 2010 using adaptations of the Household Food Insecurity Access Scale and the Medical Outcomes Study Social Support Survey. In multiple linear regression models, less instrumental social support, defined as concrete direct ways people help others (B = –0.81; 95% confidence interval [CI] –1.45 to –0.17), and decreased ownership scale based on owning material assets (B = –2.93; 95% CI –4.99 to –0.86) were significantly associated with increased food insecurity, controlling for age, education, marital status, and household size. Social support interventions geared at group capacity and resilience may be crucial adjuncts to improve and maintain the long term food security and health of persons living in low-resource regions.
Journal of Acquired Immune Deficiency Syndromes | 2015
Hickey; Charles R. Salmen; Dan Omollo; Brian Mattah; Kathryn J. Fiorella; Elvin Geng; Peter Bacchetti; Cinthia Blat; Gor Benard Ouma; Daniel Zoughbie; Robert Tessler; Marcus R. Salmen; Harold Campbell; Monica Gandhi; Starley B. Shade; Betty Njoroge; Elizabeth A. Bukusi; Craig R. Cohen
Background:Despite progress in the global scale-up of antiretroviral therapy, sustained engagement in HIV care remains challenging. Social capital is an important factor for sustained engagement, but interventions designed to harness this powerful social force are uncommon. Methods:We conducted a quasiexperimental study evaluating the impact of the Microclinic Social Network intervention on engagement in HIV care and medication adherence on Mfangano Island, Kenya. The intervention was introduced into 1 of 4 similar communities served by this clinic; comparisons were made between communities using an intention-to-treat analysis. Microclinics, composed of patient-defined support networks, participated in 10 biweekly discussion sessions covering topics ranging from HIV biology to group support and group HIV status disclosure. Nevirapine concentrations in hair were measured before and after study. Results:One hundred thirteen (74%) intervention community participants joined a microclinic group, 86% of whom participated in group HIV status disclosure. Over 22-month follow-up, intervention community participants experienced one-half the rate of ≥90-day clinic absence as those in control communities (adjusted hazard ratio: 0.48; 95% confidence interval: 0.25 to 0.92). Nevirapine hair levels declined in both study arms; in adjusted linear regression analysis, the decline was 6.7 ng/mg less severe in the intervention arm than control arm (95% confidence interval: −2.7 to 16.1). Conclusions:The microclinic intervention is a promising and feasible community-based strategy to improve long-term engagement in HIV care and possibly medication adherence. Reducing treatment interruptions using a social network approach has important implications for individual patient virologic suppression, morbidity, and mortality and for broader community empowerment and engagement in healthcare.
Journal of Acquired Immune Deficiency Syndromes | 2015
Matthew D. Hickey; Charles R. Salmen; Dan Omollo; Brian Mattah; Kathryn J. Fiorella; Elvin Geng; Peter Bacchetti; Cinthia Blat; Gor Benard Ouma; Daniel Zoughbie; Robert Tessler; Marcus R. Salmen; Harold Campbell; Monica Gandhi; Starley B. Shade; Betty Njoroge; Elizabeth A. Bukusi; Craig R. Cohen
Background:Despite progress in the global scale-up of antiretroviral therapy, sustained engagement in HIV care remains challenging. Social capital is an important factor for sustained engagement, but interventions designed to harness this powerful social force are uncommon. Methods:We conducted a quasiexperimental study evaluating the impact of the Microclinic Social Network intervention on engagement in HIV care and medication adherence on Mfangano Island, Kenya. The intervention was introduced into 1 of 4 similar communities served by this clinic; comparisons were made between communities using an intention-to-treat analysis. Microclinics, composed of patient-defined support networks, participated in 10 biweekly discussion sessions covering topics ranging from HIV biology to group support and group HIV status disclosure. Nevirapine concentrations in hair were measured before and after study. Results:One hundred thirteen (74%) intervention community participants joined a microclinic group, 86% of whom participated in group HIV status disclosure. Over 22-month follow-up, intervention community participants experienced one-half the rate of ≥90-day clinic absence as those in control communities (adjusted hazard ratio: 0.48; 95% confidence interval: 0.25 to 0.92). Nevirapine hair levels declined in both study arms; in adjusted linear regression analysis, the decline was 6.7 ng/mg less severe in the intervention arm than control arm (95% confidence interval: −2.7 to 16.1). Conclusions:The microclinic intervention is a promising and feasible community-based strategy to improve long-term engagement in HIV care and possibly medication adherence. Reducing treatment interruptions using a social network approach has important implications for individual patient virologic suppression, morbidity, and mortality and for broader community empowerment and engagement in healthcare.
Aids Care-psychological and Socio-medical Aspects of Aids\/hiv | 2016
Matthew D. Hickey; Dan Omollo; Charles R. Salmen; Brian Mattah; Cinthia Blat; Gor Benard Ouma; Kathryn J. Fiorella; Betty Njoroge; Monica Gandhi; Elizabeth A. Bukusi; Craig R. Cohen; Elvin Geng
ABSTRACT HIV treatment is life-long, yet many patients travel or migrate for their livelihoods, risking treatment interruption. We examine timely reengagement in care among patients who transferred-out or were lost-to-follow-up (LTFU) from a rural HIV facility. We conducted a cohort study among 369 adult patients on antiretroviral therapy between November 2011 and November 2013 on Mfangano Island, Kenya. Patients who transferred or were LTFU (i.e., missed a scheduled appointment by ≥90 days) were traced to determine if they reengaged or accessed care at another clinic. We report cumulative incidence and time to reengagement using Cox proportional hazards models adjusted for patient demographic and clinical characteristics. Among 369 patients at the clinic, 23(6%) requested an official transfer and 78(21%) were LTFU. Among official transfers, cumulative incidence of linkage to their destination facility was 91% at three months (95%CI (confidence intervals) 69–98%). Among LTFU, cumulative incidence of reengagement in care at the original or a new clinic was 14% at three months (95%CI 7–23%) and 60% at six months (95%CI 48–69%). In the adjusted Cox model, patients who left with an official transfer reengaged in care six times faster than those who did not (adjusted hazard ratio 6.2, 95%CI 3.4–11.0). Patients who left an island-based HIV clinic in Kenya with an official transfer letter reengaged in care faster than those who were LTFU, although many in both groups had treatment gaps long enough to risk viral rebound. Better coordination of transfers between clinics, such as assisting patients with navigating the process or improving inter-clinic communication surrounding transfers, may reduce delays in treatment during transfer and improve overall clinical outcomes.
Proceedings of the National Academy of Sciences of the United States of America | 2017
Kathryn J. Fiorella; Erin M. Milner; Charles R. Salmen; Matthew D. Hickey; Dan Omollo; Abdi Odhiambo; Brian Mattah; Elizabeth A. Bukusi; Lia C. H. Fernald; Justin S. Brashares
Significance We accept that the environment influences human health, but we know little about how human health affects the environment. However, millions of people around the world rely on natural resources for food and livelihoods and confront a high burden of illness. Experience of illness may change people’s physical capacities, outlook, and planning horizons and shape how they engage with the environment. We analyze these impacts in fishing communities of Lake Victoria, Kenya. Although illness may cause the sickest individuals not to fish, many fishers continue fishing but shift their methods. When sick, fishers use methods that are less physically demanding but illegal and environmentally destructive. Our findings suggest that environmental sustainability may be integrally shaped by the health of resource users. Understanding feedbacks between human and environmental health is critical for the millions who cope with recurrent illness and rely directly on natural resources for sustenance. Although studies have examined how environmental degradation exacerbates infectious disease, the effects of human health on our use of the environment remains unexplored. Human illness is often tacitly assumed to reduce human impacts on the environment. By this logic, ill people reduce the time and effort that they put into extractive livelihoods and, thereby, their impact on natural resources. We followed 303 households living on Lake Victoria, Kenya over four time points to examine how illness influenced fishing. Using fixed effect conditional logit models to control for individual-level and time-invariant factors, we analyzed the effect of illness on fishing effort and methods. Illness among individuals who listed fishing as their primary occupation affected their participation in fishing. However, among active fishers, we found limited evidence that illness reduced fishing effort. Instead, ill fishers shifted their fishing methods. When ill, fishers were more likely to use methods that were illegal, destructive, and concentrated in inshore areas but required less travel and energy. Ill fishers were also less likely to fish using legal methods that are physically demanding, require travel to deep waters, and are considered more sustainable. By altering the physical capacity and outlook of fishers, human illness shifted their effort, their engagement with natural resources, and the sustainability of their actions. These findings show a previously unexplored pathway through which poor human health may negatively impact the environment.
Journal of Acquired Immune Deficiency Syndromes | 2015
Matthew D. Hickey; Charles R. Salmen; Dan Omollo; Brian Mattah; Kathryn J. Fiorella; Elvin Geng; Peter Bacchetti; Cinthia Blat; Gor Benard Ouma; Daniel Zoughbie; Robert Tessler; Marcus R. Salmen; Harold Campbell; Monica Gandhi; Starley B. Shade; Betty Njoroge; Elizabeth A. Bukusi; Craig R. Cohen
Background:Many HIV-infected pregnant women identified during antenatal care (ANC) do not enroll in long-term HIV care, resulting in deterioration of maternal health and continued risk of HIV transmission to infants. Methods:We performed a cluster randomized trial to evaluate the effect of integrating HIV care into ANC clinics in rural Kenya. Twelve facilities were randomized to provide either integrated services (ANC, prevention of mother-to-child transmission, and HIV care delivered in the ANC clinic; n = 6 intervention facilities) or standard ANC services (including prevention of mother-to-child transmission and referral to a separate clinic for HIV care; n = 6 control facilities). Results:There were high patient attrition rates over the course of this study. Among study participants who enrolled in HIV care, there was 12-month follow-up data for 256 of 611 (41.8%) women and postpartum data for only 325 of 1172 (28%) women. By 9 months of age, 382 of 568 (67.3%) infants at intervention sites and 338 of 594 (57.0%) at control sites had tested for HIV [odds ratio (OR) 1.45, 95% confidence interval (CI): 0.71 to 2.82]; 7.3% of infants tested HIV positive at intervention sites compared with 8.0% of infants at control sites (OR 0.89, 95% CI: 0.56 to 1.43). The composite clinical/immunologic progression into AIDS was similar in both arms (4.9% vs. 5.1%, OR 0.83, 95% CI: 0.41 to 1.68). Conclusions:Despite the provision of integrated services, patient attrition was substantial in both arms, suggesting barriers beyond lack of service integration. Integration of HIV services into the ANC clinic was not associated with a reduced risk of HIV transmission to infants and did not appear to affect short-term maternal health outcomes.
Progress in Community Health Partnerships | 2018
Annie Chang; Kathryn J. Fiorella; Matthew D. Hickey; Charles R. Salmen; Elizabeth A. Bukusi; Craig R. Cohen; Colette L. Auerswald
(1) University of California, Berkeley–University of California, San Francisco Joint Medical Program (UC Berkeley-UCSF JMP); (2) Global Health Sciences, University of California, San Francisco (UCSF); (3) Ventura County Medical Center, Family Medicine Residency Program; (4) Department of Population Medicine and Diagnostic Sciences, Cornell University; (5) Mfangano Island Research Group, Organic Health Response; (6) Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (UCSF); (7) Microclinic International; (8) Department of Family and Community Medicine, University of Minnesota; (9) Kenya Medical Research Institute; (10) Bixby Center for Global Reproductive Health, University of California, San Francisco (UCSF); (11) Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF); (12) School of Public Health, University of California, Berkeley (UC Berkeley)
Journal of Acquired Immune Deficiency Syndromes | 2015
Matthew D. Hickey; Charles R. Salmen; Dan Omollo; Brian Mattah; Kathryn J. Fiorella; Elvin Geng; Peter Bacchetti; Cinthia Blat; Gor Benard Ouma; Daniel Zoughbie; Robert Tessler; Marcus R. Salmen; Harold Campbell; Monica Gandhi; Starley B. Shade; Betty Njoroge; Elizabeth A. Bukusi; Craig R. Cohen
Background:Despite progress in the global scale-up of antiretroviral therapy, sustained engagement in HIV care remains challenging. Social capital is an important factor for sustained engagement, but interventions designed to harness this powerful social force are uncommon. Methods:We conducted a quasiexperimental study evaluating the impact of the Microclinic Social Network intervention on engagement in HIV care and medication adherence on Mfangano Island, Kenya. The intervention was introduced into 1 of 4 similar communities served by this clinic; comparisons were made between communities using an intention-to-treat analysis. Microclinics, composed of patient-defined support networks, participated in 10 biweekly discussion sessions covering topics ranging from HIV biology to group support and group HIV status disclosure. Nevirapine concentrations in hair were measured before and after study. Results:One hundred thirteen (74%) intervention community participants joined a microclinic group, 86% of whom participated in group HIV status disclosure. Over 22-month follow-up, intervention community participants experienced one-half the rate of ≥90-day clinic absence as those in control communities (adjusted hazard ratio: 0.48; 95% confidence interval: 0.25 to 0.92). Nevirapine hair levels declined in both study arms; in adjusted linear regression analysis, the decline was 6.7 ng/mg less severe in the intervention arm than control arm (95% confidence interval: −2.7 to 16.1). Conclusions:The microclinic intervention is a promising and feasible community-based strategy to improve long-term engagement in HIV care and possibly medication adherence. Reducing treatment interruptions using a social network approach has important implications for individual patient virologic suppression, morbidity, and mortality and for broader community empowerment and engagement in healthcare.